International Experts Discuss Key Learnings from the ADA’s 79th Scientific Sessions for Physicians

Duration

1 hr

Profession

Physician

# of Credits

1

Accreditation

Mainpro+

Expiry Date

2020-10-09

During the 79th Scientific Sessions of the American Diabetes Association (ADA) several key trials were presented on a number of antihyperglycemic agents.

​This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 1 Mainpro+ Credit(s). Cert+ Program ID#: 190712

N/A

Peter Lin, MD, CCFP David C.W. Lau, MD, PhD, FRCPC Thomas Round, MBBS, BSc, DRCOG, MRCGP David Strain, MB, ChB, BSc (Hons) MD, FRCP Elizabeth Rosolowsky, MD, MPH, FAAP, FRCPC Robyn L. Houlden, MD, FRCPC John Axler, MD, CCFP, FCFP Deanna Telner, MD, MEd, CCFP, FCFP Jeffrey Habert, MD, CCFP, FCFP

Upon completion of this program, participants will be able to: Discuss the impact of behavioural (lifestyle) modifications on the management of type 2 diabetes Determine how specific patient factors can help with the individualization of antihyperglycemic therapies Review the differences in management of a healthy older adult and one with significant comorbidities, polypharmacy and frailty Summarize the key clinical trials presented at the ADA 79th Scientific Sessions



Related Courses